Tom Martin

Statistics

Publications

Citations

1.4K

H-Index

Active since

1982

Affiliations

University of California, San Francisco(Current)

City of Hope

Levine Cancer Institute

Janssen (United States)

Dana-Farber Cancer Institute

Tom Martin is an author at University of California, San Francisco specializing in multiple myeloma therapy, multiple myeloma treatment, and relapsed multiple myeloma.

Publications per year

1982–2025

Publications

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 380 citations

Medicine, Pharmacology, Pharmacotherapy +12

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Joseph Mıkhael, Nofisat Ismaila, Matthew C. Cheung et al. · Journal of Clinical Oncology · 2019 · 333 citations

Medicine, Oncology, Radiation Oncology +15

Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma

Michael Wang, Tom Martin, William Bensinger et al. · Blood · 2013 · 128 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Perifosine Plus Bortezomib and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Previously Treated With Bortezomib: Results of a Multicenter Phase I/II Trial

Paul G. Richardson, J. Wolf, Andrzej Jakubowiak et al. · Journal of Clinical Oncology · 2011 · 119 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses

Meixue Duan, Doan C. Nguyen, Chester J. Joyner et al. · Cell Reports · 2023 · 74 citations · Full text

Life Sciences, Cell Biology, Immunology +16

1–5 of 17